Unknown

Dataset Information

0

Type I interferon shapes the quantity and quality of the anti-Zika virus antibody response.


ABSTRACT: Objectives:Zika virus (ZIKV) is a mosquito-borne flavivirus that re-emerged in 2015. The association between ZIKV and neurological complications initiated the development of relevant animal models to understand the mechanisms underlying ZIKV-induced pathologies. Transient inhibition of the type I interferon (IFN) pathway through the use of an IFNAR1-blocking antibody, MAR1-5A3, could efficiently permit active virus replication in immunocompetent animals. Type I IFN signalling is involved in the regulation of humoral responses, and thus, it is crucial to investigate the potential effects of type I IFN blockade towards B-cell responses. Methods:In this study, comparative analysis was conducted using serum samples collected from ZIKV-infected wild-type (WT) animals either administered with or without MAR1-5A3. Results:Serological assays revealed a more robust ZIKV-specific IgG response and subtype switching upon inhibition of type I IFN due to the abundance of antigen availability. This observation was corroborated by an increase in germinal centres, plasma cells and germinal centre B cells. Interestingly, although both groups of animals recognised different B-cell linear epitopes in the E and NS1 regions, there was no difference in neutralising capacity. Further characterisation of these epitopes in the E protein revealed a detrimental role of antibodies that were generated in the absence of type I IFN. Conclusion:This study highlights the role of type I IFN in shaping the anti-ZIKV antibody response to generate beneficial antibodies and will help guide development of better vaccine candidates triggering efficient neutralising antibodies and avoiding detrimental ones.

SUBMITTER: Lee CY 

PROVIDER: S-EPMC7184064 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Type I interferon shapes the quantity and quality of the anti-Zika virus antibody response.

Lee Cheryl Yi-Pin CY   Carissimo Guillaume G   Chen Zheyuan Z   Lum Fok-Moon FM   Abu Bakar Farhana F   Rajarethinam Ravisankar R   Teo Teck-Hui TH   Torres-Ruesta Anthony A   Renia Laurent L   Ng Lisa Fp LF  

Clinical & translational immunology 20200426 4


<h4>Objectives</h4>Zika virus (ZIKV) is a mosquito-borne <i>flavivirus</i> that re-emerged in 2015. The association between ZIKV and neurological complications initiated the development of relevant animal models to understand the mechanisms underlying ZIKV-induced pathologies. Transient inhibition of the type I interferon (IFN) pathway through the use of an IFNAR1-blocking antibody, MAR1-5A3, could efficiently permit active virus replication in immunocompetent animals. Type I IFN signalling is i  ...[more]

Similar Datasets

2020-11-03 | PXD016398 | Pride
| S-EPMC6791859 | biostudies-other
| S-EPMC5249252 | biostudies-literature
| S-EPMC5283583 | biostudies-literature
| S-EPMC8515865 | biostudies-literature
| S-EPMC4900918 | biostudies-literature
| S-EPMC6538335 | biostudies-literature
| S-EPMC6340140 | biostudies-literature
| S-EPMC5289613 | biostudies-literature
| S-EPMC6879226 | biostudies-literature